Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 3 of 35

RECRUITING NA

Virtual 1-Session Spanish "Empowered Relief" Group Intervention for Chronic Pain

NCT04546685

RECRUITING Phase 4

OnabotulinumtoxinA for Trigeminal Neuralgia

NCT06216886

RECRUITING

Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping

NCT06941662

RECRUITING

Evaluating a New Mental Health Group for Asians and Asian Americans

NCT06185959

RECRUITING NA

Studying Melatonin and Recovery in Teens

NCT06093477

RECRUITING Phase 1

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

NCT06408194

RECRUITING NA

REHAB Fontan Failure: A Trial of Cardiac Rehabilitation

NCT06150950

RECRUITING Phase 4

Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?

NCT05396144

RECRUITING NA

Prostate Stimulation for Sexual Dysfunction

NCT05468931

RECRUITING NA

Beneficial Exposome Study

NCT06093464

RECRUITING Phase 1

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

NCT06138132

RECRUITING Phase 1

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

NCT06340737

RECRUITING NA

Double-S: a Wearable Device for Erectile Dysfunction

NCT05451563

RECRUITING NA

Identifying Markers of Exercise Training in Heart Failure

NCT05696652

RECRUITING Phase 2

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

NCT05940324

RECRUITING NA

Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic Stress

NCT05701111

RECRUITING NA

Effects of Movement Retraining on Knee Loading in Individuals With Knee Osteoarthritis

NCT06208631

RECRUITING Phase 1

CogT pSOPT Intervention Study

NCT06005038

RECRUITING Phase 2

Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD

NCT05268796

RECRUITING Phase 3

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

NCT06173401

RECRUITING NA

Detection of EEG-Based Biomarkers of Chronic Low Back Pain

NCT06025201

RECRUITING NA

Food FARMacia: Reducing Childhood Obesity in Households With Food Insecurity

NCT06051591

RECRUITING NA

Subscapularis Repair Augmentation for Total Shoulder Arthroplasty

NCT05487677

RECRUITING NA

Behavioral and Neuronal Correlates of Human Mood States

NCT06159595

RECRUITING NA

Evaluation of Combination Therapy for Upper Extremity Lymphedema

NCT05825157

RECRUITING NA

Blossom® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction

NCT05975372

RECRUITING

Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease

NCT06215222

RECRUITING Phase 2

Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity

NCT05912621

RECRUITING NA

Dynamic Versus Static Night Splinting of Plantar Fasciitis

NCT05432895

RECRUITING Phase 1

Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

NCT06080061

RECRUITING NA

Improving Social Communication in Individuals With ASD Using AI

NCT05987774

RECRUITING Phase 2

5-Day Preoperative Radiation for Soft Tissue Sarcoma

NCT06087861

RECRUITING Phase 1

HNC: Human Neural Circuits Electrophysiology During Cognition

NCT05962424

RECRUITING NA

Assessment of the Interi Manifold in Implant-Based Breast Reconstruction

NCT05975359

RECRUITING NA

Addressing Diabetes by Elevating Access to Nutrition

NCT05228860

RECRUITING NA

PRT for Adolescents With High Functioning Autism

NCT05987761

RECRUITING NA

Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans

NCT05996900

RECRUITING Phase 2

Trial of Zolpidem for Sleep in Children With Autism

NCT05540574

RECRUITING Phase 2

Trial of Diphenhydramine for Sleep in Children With Autism

NCT05501678

RECRUITING Phase 2

Trial of Suvorexant for Sleep in Children With Autism

NCT05546554

RECRUITING

Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

NCT05880797

RECRUITING

Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

NCT05865301

RECRUITING NA

Technology-enabled Management Versus Usual Care for Blood Pressure

NCT05479461

RECRUITING NA

Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2

NCT05833217

RECRUITING Early Phase 1

Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study

NCT05912387

RECRUITING Phase 1

Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

NCT05794958

RECRUITING NA

Interventions in Mathematics and Cognitive Skills

NCT05201534

RECRUITING NA

Parent Intervention for Psychiatrically-Hospitalized Youth

NCT04797455

RECRUITING NA

Improving Blood Pressure Control in Stroke Patients by Increasing Access to a Home Blood Pressure Monitor

NCT05730465

RECRUITING Phase 2

Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial

NCT05664789

← Previous Page 3 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.